ArticleDiscover nano2026
Biosynthesis of gold nanoparticles from Solanum marginatum and its enhanced anti inflammatory activity in LPS induced RAW 264.7 cell lines.
Article in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nowadays, there is an increase in the demand for plant-extract-mediated nanoparticles, mainly due to low toxicity and biocompatibility, which owing to their enhanced bioavailability, exhibit significant antibacterial, anti-inflammatory, antitumoral, and antiviral activities. However, green synthesis of gold nanoparticles (SM-Au NPs) offers a sustainable targeted and effective way for drug delivery. This study first report to our knowledge demonstrated that gold nanoparticles (SM-Au NPs) synthesized from aqueous leaf extract of Solanum marginatum (SM), evaluated their in-vitro anti-inflammatory activity and their underlying mechanism in Lipopolysaccharide (LPS) induced RAW 264.7 cells. The peak at UV-Vis 540 nm confirmed formation of SM-Au NPs. Dynamic light scattering (DLS) of SM-Au NPs revealed a hydrodynamic size of 1253.3 nm and zeta potential of - 21.1 mV. X-ray diffraction (XRD) analysis revealed that SM-Au NPs were crystalline and pure with an average crystal size of 22.3 nm. The cytotoxicity results confirmed that SM-Au NPs were found to be did not show cytotoxic effect within the concentration of 6.25-12.5 µg/mL against RAW 264.7 macrophages. SM-Au NPs inhibited nitric oxide (NO) production in a dose-dependent manner showing 45.31% inhibition at 12.5 µg/mL with IC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.